The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | Silver Ronald | PFO & PAO | Sell(S) | 128K | $4.52 | $578K |
| Jun 16, 2026 | Moukheibir Catherine | Director | Grant(A) | 63K | — | $0 |
| Jun 16, 2026 | Shepard Jay | Director | Grant(A) | 63K | — | $0 |
| Jun 16, 2026 | Kessler Marla L | Director | Grant(A) | 63K | — | $0 |
| Jun 16, 2026 | Currie Mark G | Director | Grant(A) | 63K | — | $0 |
| Jun 16, 2026 | Denner Alexander J | Director | Grant(A) | 63K | — | $0 |
| Jun 16, 2026 | McHugh Julie | Director | Grant(A) | 63K | — | $0 |
| Jun 16, 2026 | McHugh Julie | Director | Sell(S) | 22K | $3.73 | $80K |
| Jun 16, 2026 | Duane Jon R | Director | Grant(A) | 63K | — | $0 |
| Jun 15, 2026 | Denner Alexander J | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Silver Ronald | PFO & PAO | Grant(A) | 25K | — | $0 |
| Mar 17, 2026 | Denner Alexander J | Director | Sell(S) | 6K | $3.31 | $19K |
| Mar 17, 2026 | Denner Alexander J | Director | Sell(S) | 6.7M | $3.05 | $20.5M |
| Mar 13, 2026 | Denner Alexander J | Director | Grant(A) | 4K | — | $0 |
| Mar 10, 2026 | MCCOURT Thomas A | Chief Executive Officer, Director | Grant(A) | 410K | — | $0 |
| Mar 10, 2026 | Martini Gregory S. | Chief Financial Officer | Grant(A) | 137K | — | $0 |
| Mar 10, 2026 | John Minardo | Chief Legal Officer | Grant(A) | 137K | — | $0 |
| Mar 10, 2026 | Silver Ronald | Principal Accounting Officer | Grant(A) | 164K | — | $0 |
| Mar 10, 2026 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Grant(A) | 137K | — | $0 |
| Mar 10, 2026 | Gaskins Tammi L | Chief Commercial Officer | Grant(A) | 137K | — | $0 |
| Feb 24, 2026 | Silver Ronald | Principal Accounting Officer | Sell(S) | 13K | $3.66 | $46K |
| Feb 24, 2026 | MCCOURT Thomas A | Chief Executive Officer, Director | Sell(S) | 104K | $3.66 | $379K |
| Feb 24, 2026 | Gaskins Tammi L | Chief Commercial Officer | Sell(S) | 11K | $3.66 | $41K |
| Feb 24, 2026 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Buy(S) | 17K | $3.66 | $62K |
| Feb 24, 2026 | John Minardo | Chief Legal Officer | Sell(S) | 19K | $3.66 | $70K |
| Feb 24, 2026 | Martini Gregory S. | Chief Financial Officer | Sell(S) | 11K | $3.66 | $42K |
| Feb 23, 2026 | Silver Ronald | Principal Accounting Officer | Sell(S) | 12K | $3.81 | $44K |
| Feb 23, 2026 | MCCOURT Thomas A | Chief Executive Officer, Director | Sell(S) | 95K | $3.81 | $361K |
| Feb 23, 2026 | Gaskins Tammi L | Chief Commercial Officer | Sell(S) | 10K | $3.81 | $39K |
| Feb 23, 2026 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Sell(S) | 16K | $3.81 | $59K |
| Feb 23, 2026 | John Minardo | Chief Legal Officer | Sell(S) | 17K | $3.81 | $66K |
| Feb 23, 2026 | Martini Gregory S. | Chief Financial Officer | Sell(S) | 10K | $3.81 | $40K |
| Jan 5, 2026 | Silver Ronald | Principal Accounting Officer | Sell(S) | 35K | $4.60 | $163K |
| Dec 15, 2025 | Denner Alexander J | Director, 10% Owner | Grant(A) | 4K | — | $0 |
| Nov 17, 2025 | Gaskins Tammi L | Chief Commercial Officer | Sell(S) | 6K | $3.32 | $20K |
| Sep 15, 2025 | Denner Alexander J | Director, 10% Owner | Grant(A) | 12K | — | $0 |
| Aug 11, 2025 | Martini Gregory S. | Chief Financial Officer | Sell(S) | 1K | $0.84 | $1K |
| Aug 11, 2025 | Silver Ronald | Principal Accounting Officer | Sell(S) | 3K | $0.84 | $2K |
| Aug 11, 2025 | John Minardo | Chief Legal Officer | Sell(S) | 8K | $0.84 | $7K |
| Aug 11, 2025 | Gaskins Tammi L | Chief Commercial Officer | Sell(S) | 1K | $0.84 | $1K |
| Jun 13, 2025 | Sarissa Capital Management LP | 10% Owner | Grant(A) | 24K | — | $0 |
| Jun 10, 2025 | Denner Alexander J | Director, 10% Owner | Grant(A) | 45K | — | $0 |
| Jun 10, 2025 | Dreyfus Andrew | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2025 | McHugh Julie | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2025 | Currie Mark G | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2025 | Duane Jon R | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2025 | Moukheibir Catherine | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2025 | Shepard Jay | Director | Grant(A) | 45K | — | $0 |
| Jun 10, 2025 | Kessler Marla L | Director | Grant(A) | 45K | — | $0 |
| May 20, 2025 | MCCOURT Thomas A | Chief Executive Officer, Director | Grant(A) | 540K | — | $0 |
| May 16, 2025 | Gaskins Tammi L | Chief Commercial Officer | Sell(S) | 3K | $0.58 | $1K |
| May 16, 2025 | MCCOURT Thomas A | Chief Executive Officer, Director | Sell(S) | 13K | $0.58 | $8K |
| Apr 2, 2025 | Sarissa Capital Management LP | 10% Owner | Grant(A) | 10K | — | $0 |
| Feb 10, 2025 | Martini Gregory S. | Chief Financial Officer | Sell(S) | 12K | $1.76 | $21K |
| Feb 10, 2025 | John Minardo | Chief Legal Officer | Sell(S) | 39K | $1.76 | $69K |
| Feb 10, 2025 | John Minardo | Chief Legal Officer | Grant(A) | 122K | — | $0 |
| Feb 10, 2025 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Grant(A) | 133K | — | $0 |
| Feb 10, 2025 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Sell(S) | 41K | $1.76 | $73K |
| Feb 10, 2025 | Silver Ronald | Principal Accounting Officer | Sell(S) | 12K | $1.76 | $21K |
| Feb 10, 2025 | MCCOURT Thomas A | Chief Executive Officer, Director | Sell(S) | 139K | $1.76 | $245K |
| Jan 27, 2025 | Martini Gregory S. | Chief Financial Officer | Grant(A) | 111K | — | $0 |
| Jan 27, 2025 | Silver Ronald | Principal Accounting Officer | Grant(A) | 133K | — | $0 |
| Jan 17, 2025 | MCCOURT Thomas A | Chief Executive Officer, Director | Grant(A) | 147K | — | $0 |
| Jan 17, 2025 | John Minardo | Chief Legal Officer | Grant(A) | 40K | — | $0 |
| Jan 17, 2025 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Grant(A) | 48K | — | $0 |
| Dec 16, 2024 | Sarissa Capital Management LP | 10% Owner | Grant(A) | 4K | — | $0 |
| Nov 18, 2024 | Emany Sravan Kumar | SVP, COO and CFO | Sell(S) | 11K | $4.08 | $45K |
| Nov 18, 2024 | Davis Andrew | SVP, Chief Business Officer | Sell(S) | 5K | $4.08 | $22K |
| Sep 16, 2024 | Sarissa Capital Management LP | 10% Owner | Grant(A) | 3K | — | $0 |
| Aug 12, 2024 | Silver Ronald | Principal Accounting Officer | Sell(S) | 3K | $4.27 | $13K |
| Aug 12, 2024 | John Minardo | Chief Legal Officer | Sell(S) | 10K | $4.27 | $42K |
| Jun 18, 2024 | Currie Mark G | Director | Grant(A) | 24K | — | $0 |
| Jun 18, 2024 | Kessler Marla L | Director | Grant(A) | 24K | — | $0 |
| Jun 18, 2024 | Duane Jon R | Director | Grant(A) | 24K | — | $0 |
| Jun 18, 2024 | McHugh Julie | Director | Grant(A) | 24K | — | $0 |
| Jun 18, 2024 | Dreyfus Andrew | Director | Grant(A) | 24K | — | $0 |
| Jun 18, 2024 | Shepard Jay | Director | Grant(A) | 24K | — | $0 |
| Jun 18, 2024 | Denner Alexander J | Director, 10% Owner | Grant(A) | 24K | — | $0 |
| Jun 18, 2024 | Moukheibir Catherine | Director | Grant(A) | 24K | — | $0 |
| Jun 15, 2024 | Sarissa Capital Management LP | 10% Owner | Grant(A) | 3K | — | $0 |
| Jun 10, 2024 | McHugh Julie | Director | Sell(S) | 23K | $6.29 | $143K |
| Jun 7, 2024 | Moukheibir Catherine | Director | Sell(S) | 36K | $6.61 | $235K |
| Jun 6, 2024 | Moukheibir Catherine | Director | Sell(S) | 44K | $6.36 | $283K |
| May 20, 2024 | John Minardo | Chief Legal Officer | Sell(S) | 17K | $6.45 | $112K |
| May 20, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell(S) | 16K | $6.45 | $104K |
| May 20, 2024 | Davis Andrew | SVP, Chief Business Officer | Sell(S) | 23K | $6.45 | $147K |
| May 20, 2024 | MCCOURT Thomas A | Chief Executive Officer, Director | Sell(S) | 68K | $6.45 | $436K |
| May 16, 2024 | Emany Sravan Kumar | SVP, Chief Financial Officer | Tax withholding(F) | 18K | $6.64 | $121K |
| Mar 15, 2024 | Denner Alexander J | Director, 10% Owner | Grant(A) | 2K | — | $0 |
| Mar 8, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Option exercise(M) | 35K | — | $0 |
| Mar 8, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Option exercise(M) | 35K | — | $0 |
| Mar 8, 2024 | Emany Sravan Kumar | SVP, Chief Financial Officer | Option exercise(M) | 37K | — | $0 |
| Mar 8, 2024 | Emany Sravan Kumar | SVP, Chief Financial Officer | Option exercise(M) | 37K | — | $0 |
| Mar 8, 2024 | John Minardo | Chief Legal Officer | Option exercise(M) | 33K | — | $0 |
| Mar 8, 2024 | John Minardo | Chief Legal Officer | Option exercise(M) | 33K | — | $0 |
| Mar 8, 2024 | MCCOURT Thomas A | Chief Executive Officer, Director | Option exercise(M) | 120K | — | $0 |
| Mar 8, 2024 | MCCOURT Thomas A | Chief Executive Officer, Director | Option exercise(M) | 120K | — | $0 |
| Mar 8, 2024 | Davis Andrew | SVP, Chief Business Officer | Option exercise(M) | 37K | — | $0 |
| Mar 8, 2024 | Davis Andrew | SVP, Chief Business Officer | Option exercise(M) | 37K | — | $0 |
| Mar 6, 2024 | Duane Jon R | Director | Buy(P) | 7K | $8.70 | $60K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).